Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) EPS (Weighted Average and Diluted) (2023 - 2025)

Upstream Bio (UPB) has 3 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.63 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 90.95% year-over-year to -$0.63; the TTM value through Sep 2025 reached $10.68, up 152.74%, while the annual FY2024 figure was -$5.58, 56.91% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.63 in Q3 2025 per UPB's latest filing, up from -$0.74 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $12.56 in Q4 2024 and bottomed at -$6.96 in Q3 2024.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$1.2, with a median of -$1.42 recorded in 2025.
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 229.86% in 2024, then soared 90.95% in 2025.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$2.11 in 2023, then skyrocketed by 695.26% to $12.56 in 2024, then plummeted by 105.02% to -$0.63 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.63 in Q3 2025, -$0.74 in Q2 2025, and -$0.51 in Q1 2025.